Chemical Compound
10-Hydroxycamptothecin
CAS Registry Number
19685-09-7
Primary Record
10-Hydroxycamptothecin
- In stock
- 3,661 g
- Purity
- 98.7 %
- CAS
- 19685-09-7
Compound Identifiers & Properties
- CAS
- 19685-09-7
- PubChem CID
- 97226
- SMILES
- CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=CC5=C4)O)O
- Canonical SMILES
- CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3cc(O)ccc3nc2-1
Names & Synonyms
- 10-Hydroxycamptothecin
- (S)-10-Hydroxycamptothecin
- Hydroxycamptothecin
- 19685-09-7
- 10-hydroxycamptothecine
- Hydroxycamptothecine
- 10-Hydroxy camptothecin
- Camptothecin, hydroxy-
- Hydroxy camptothecine
- HCPT
- HCPT cpd
- hydroxycamptothecinum
- 10-Hydroxy-Camptothecin
- 10-HCPT
- Hydroxycamptothecin-10
- 10-Hydroxy-CPT
- Camptothecine, 10-hydroxy-
- Irinotecan related compound a
- Camptothecin, 10-hydroxy-
- 10hydroxy camptothecin
- 10-Hydroxycamptochecin
- Spectrum_001639
- 10-Hydroxycamp-totecin
- RefChem:77529
- SpecPlus_000763
- 10 hydroxy Camptothecin
- Spectrum2_001660
- Spectrum3_001621
- Spectrum4_001815
- Spectrum5_000549
- Trifluoromethylhypofluorite
- ethyl(dihydroxy)[?]dione
- Irinotecan EP Impurity B
- 7-ethy hydroxycamptothecin
- MFCD02093100
- D07ILP
- UNII-9Z01632KRV
- AC1L3Y2F
- AC1Q6AQ3
- CHEMBL273862
- 9Z01632KRV
- C20H16N2O5
- (20S)-10-Hydroxycamptothecin
- SCHEMBL25875
- BSPBio_003281
- KBioGR_002454
- KBioSS_002119
- (S)-10-Hydroxycamptothecin hydrate
- CAMPTOTHECIN, 10-HYDROXY
- DivK1c_006859
- NSC 107124
- NSC-107124
- SPECTRUM1504123
- SPBio_001819
- (4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- HAWSQZCWOQZXHI-FQEVSTJZSA-N
- NSC107124
- orb1305050
- SCHEMBL29350707
- (S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- CHEBI:81395
- CTK8B3047
- ERK5-7I05
- HY-N0095R
- KBio1_001803
- KBio2_002119
- KBio2_004687
- KBio2_007255
- KBio3_002501
- Camptothecin 10-Hydroxy Impurity
- DTXSID00941444
- DTXSID90987018
- EX-A988
- ZNTSSYJZVXCQGE-FQEVSTJZSA-N
- KST-1A7243
- 10-Hydroxycamptothecin, food grade
- AOB33756
- BCP01385
- CID97226
- EBD37036
- HY-N0095
- ZINC3979155
- (+)-10-HYDROXYCAMPTOTHECIN
- 2136AH
- ANW-41680
- AR-1A6082
- BDBM50008922
- CCG-38770
- CH-068
- CH0082
- CID:97226
- EBC-17074
- MSK157282
- s2423
- s3898
- (+)-(S)-10-HYDROXYCAMPTOTHECIN
- 64439-81-2
- AKOS015919293
- AC-5502
- ACN-035239
- AN-1351
- BCP9000058
- CS-5193
- CS-O-06296
- DB12385
- RL02475
- (S)-10-Hydroxycamptothecin (Standard)
- C20-H16-N2-O5.H2-O
- 10-HYDROXYCAMPTOTHECIN [WHO-DD]
- NCGC00095986-01
- NCGC00095986-02
- NCGC00095986-03
- NCGC00095986-04
- NCGC00178165-01
- AC-13221
- AJ-47579
- AK-33939
- AN-38748
- AS-13196
- BR-33939
- H577
- NCI60_000173
- SC-19239
- SID:53787862
- SID:76715604
- SY010687
- AB0013128
- J258.662B
- LS-127397
- TL8001609
- TR-009134
- Camptothecin, 10-Hydroxy-, Camptotheca acuminata
- FT-0607192
- FT-0689364
- H1463
- N2591
- NS00018317
- ST24032108
- J3.021.724A
- 10-hydroxycamptothecin;10-hydroxy camptothecin
- 85H097
- A11997
- A25382
- C17939
- IRINOTECAN RELATED COMPOUND A [USP-RS]
- M-1114
- (S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4'
- C028098
- C527042
- EN300-19810684
- F787618
- SR-05000002620
- SR-05000002620-1
- 50P550528
- BRD-K63784565-001-02-1
- BRD-K63784565-001-03-9
- BRD-K63784565-001-05-4
- BRD-K63784565-001-06-2
- Q27155328
- 67656-30-8
- Z3093896188
- (4s)-4-ethyl-4,9-dihydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]chinolin-3,14(4h,12h)-dion
- 50P550528001
- B2703-086753
- Irinotecan EP Impurity B; Camptothecin 10-Hydroxy Impurity
- (19S)-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
- (S)-4-ethyl-4,9-dihydroxy-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione
- 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, hydrate, (S)-
- (20S)-4-Ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
- (S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione ((S)-10-Hydroxycamptothecin)
- 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione-,4-ethyl-4,9-dihydroxy-, (S)-
- 6628-69-9
- 10-Hydroxycamptothecin, 98%, from Taxus chinensis (Pilg.) Rehder - 10MG 10mg
- 4-Ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
- (+/-)-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLINE-3,14(4H,12H)-DIONE
- (19S)-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo(11.8.0.02,11.04,9.015,20)henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
- (19S)-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
- (4S)-4,9-Dihydroxy-4-ethyl-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- (4S)-4,9-Dihydroxy-4-ethyl-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
- (4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- (4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 10-Hydroxycamptothecin; 10-Hydroxycamptothecine; NSC 107124
- (4S)-4-Ethyl-4beta,9-dihydroxy-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
- (4S)-4alpha-Ethyl-4,9-dihydroxy-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
- (4S)-4alpha-Ethyl-4beta,9-dihydroxy-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- (4S)-9-Hydroxy-4-hydroxy-4-ethyl-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- (alphaS)-alpha,2-Dihydroxy-alpha-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinoline-7-acetic acid 7,8-lactone
- (S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3 inverted exclamation mark ,4 inverted exclamation mark :6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione
- (S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione
- 130194-92-2
- 1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H,12H)-DIONE, 4-ETHYL-4,9-DIHYDROXY-, (4S)-
- 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, (4S)-; 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, (S)-; Camptothecine, 10-hydroxy- (8CI); (+)-10-Hydroxycamptothecin; (S)-10-Hydroxycamptothecin; 10-Hydroxycamptothecin; 10-Hydroxycamptothecine; ChEMBL 273862; Hydroxycamptothecin; NSC 107124; (S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3'4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; Topotecan related; SKF-S-104961; Irinotecan Related Compound A; Irinotecan Hydrochloride Trihydrate Impurity B; Irinotecan Impurity B
- 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-,4-ethyl-4,9-dihydroxy-, (S)-
- 1H-Pyrano[3',7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-,4-ethyl-4,9-dihydroxy-, (S)-
- 4-Ethyl-4,10-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
- 4-Ethyl-4,10-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- 4-Ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (10-hydroxycamptothecin)
- 4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- 613-598-9